UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Dan Dumesic, MD

Print
Email

Daniel Dumesic, MD

UCLA Physician Daniel Dumesic, MD specializes in Reproductive Endocrinology.
Preferred Name
Dan Dumesic
Specialty
Reproductive Endocrinology
Gender
Male
Language Spoken
English
Hospital Affiliation
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica
State License Number
G42468
Contact
(310) 794-7274 Appointments
Email Address
ddumesic@mednet.ucla.edu
Follow me on ShareCare
PRACTICE LOCATION

UCLA Department of Obstetrics and Gynecology
Peter Morton Medical Building
200 Medical Plaza, Suites 220
Los Angeles, CA 90095

MEDICAL BOARD CERTIFICATION
Reproductive Endocrinology, American Board of Obstetrics and Gynecology, 1989, 2013
Obstetrics & Gynecology, American Board of Obstetrics and Gynecology, 1984, 2013
EDUCATION
Fellowship
Reproductive Endocrinology, UCSF Medical Center, 1985 - 1987
Residency
Obstetrics & Gynecology, UCSF Medical Center, 1980 - 1982
Obstetrics & Gynecology, University of Minnesota Medical School, 1978 - 1980
Medical Degree
MD, University of Wisconsin Medical School, 1978
CLINICAL INTEREST
Abnormal Breast Milk, Hirsutism & Masculinization, In Vitro Fertilization, Infertility, Polycystic Ovarian Syndrome, Recurrent Pregnancy Loss, Reproductive Endocrinology
AFFILIATION
WEBINARS
MORE INFORMATION
Research Interest
  • Polycystic Ovary Syndrome (PCOS).  Link to PCOS Clinical Study »
  • Oocyte development and assisted reproductive techniques (ART) Nonhuman primate models of PCOS
  • Developmental programming of adult diseases

Support The Women's Healthcare Research Fund »

Awards & Recognition
  • Mayo Award for Excellence in Leadership
Publications

Selected articles from the past 5 years:

  • Allemand MC, Phy JL, Foong SC, Dumesic DA, Session DR, Tummon IS. Diagnosis of polycystic ovaries by three-dimensional transvaginal ultrasound. Fertil Steril 2006;85:214-219.
  • Zhou R, Bird IM, Dumesic DA, Abbott DH. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:6630-6637.
  • Foong SC, Abbott DH, Zschunke MA, Lesnick TG, Phy JL, Dumesic DA. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome (PCOS) patients undergoing gonadotropin therapy for in vitro fertilization J Clin Endocrinol Metab. 2006;91:2327-2333.
  • Abbott DH, Padmanabhan V and Dumesic DA. 2006 Contributions of androgen and estrogen to fetal programming of ovarian dysfunction. Reproductive Biology and Endocrinology 4:17.
  • Wood JR, Dumesic DA, Abbott DH, Strauss JF. Molecular Abnormalities in Oocytes from Women with Polycystic Ovary Syndrome Revealed by Microarray Analysis. J Clin Endocrinol Metab. 2007;92:705-713.
  • Dumesic DA, Lesnick TG, Abbott DH. Increased Adiposity Enhances Intrafollicular Estradiol levels in Normoandrogenic Ovulatory Women Receiving GnRH Analog/Recombinant Human FSH Therapy for In Vitro Fertilization. J Clin Endocrinol Metab 2007;92:1438-1441.
  • Zhou R, Bruns CM, Bird IM, Kemnitz JW, Goodfriend TL, Dumesic DA, Abbott DA. Pioglitazone improves insulin action and normalizes menstrual cycles in a nonhuman primate model of polycystic ovary syndrome. Reprod Toxicol 2007;23:438-448.
  • Dumesic DA, Abbott DH, Padmanabhan V. PCOS and its Developmental Origins. Rev Endocr Metab Disord 2007;8:127-141.
  • Michailidou Z, Jensen MD, Dumesic D, Chapman KE, Seckl JR, Walker BR, Morton NM. Omental fat 11ß-hydroxysteroid dehydrogenase type 1 correlates with fat cell size independently of obesity. Obesity 2007;15:1155-1163.
  • Bruns CM, Baum ST, Colman RJ, Dumesic DA, Eisner JR, Jensen MD, Whigham LD, Abbott DH Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome. Int J Obes 2007;31:1579-1585.
  • Votruba SB, Mattison RS, Dumesic DA, Koutsauri C, Jensen MD. Meal fatty acid uptake in visceral fat in women. Diabetes 2007;56:2589-2597.
  • Padmanabhan V, Veiga-Lopez A, Abbott D, Dumesic D. Developmental programming of ovarian dysfunction. New Concepts in Ovarian Endocrinology. 2007; 329-352.
  • Dumesic DA, Padmanabhan V, Abbott DH. Polycystic ovary syndrome and oocyte developmental competence. Obstet Gynecol Surv 2008;63(1):39-48.
  • Dumesic DA, Abbott DH. Implications of polycystic ovary syndrome on oocyte development. Semin Reprod Med 2008;26(1):53-61.
  • Koutsari C, Dumesic DA, Patterson BW, Votruba SB, Jensen MD. Plasma free fatty acid storage into subcutaneous and visceral adipose tissue in postabsorptive women. Diabetes 2008;57:1186-1194.
  • Abbott DH, Barnett DK, Levine JE, Padmanabhan V, Dumesic DA, Jacoris S, Tarantal AF. Endocrine Antecedents of Polycystic Ovary Syndrome in Fetal and Infant Prenatally Androgenized Female Rhesus Monkeys. Biol Reprod. 2008, 79:154-163.
  • Abbott DH, Zhou R, Bird IM, Dumesic DA, Conley AJ. Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome. Endocr Dev 2008;13:145-58.
  • Steckler TL, Herkimer C, Dumesic D, Padmanabhan V. Developmental Programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity- implication to PCOS. Endocrinology 2009;150:1456-65.
  • Abbott DH, Tarantal AF, Dumesic DA. Fetal, Infant, Adolescent and Adult Phenotypes of Polycystic Ovary Syndrome in Prenatally Androgenized Female Rhesus Monkeys. Am J Primatol 2009;71:776-784.
  • Abbott DH, Dumesic DA. Fetal androgen excess provides a developmental origin for polycystic ovary syndrome. Expert Rev Obstet Gynecol 2009;4:1-7.
  • Dumesic DA, Lesnick TG, Stassart JP, Ball GD, Wong A, Abbott DH. Intrafollicular antimullerian hormone (AMH) levels predict follicle responsiveness to FSH in normoandrogenic ovulatory women undergoing GnRH analog/recombinant human FSH therapy for IVF-ET. Fertil Steril 2009;92:217-221.
  • Grant CS, Ingle JN, Suman VJ, Dumesic DA, Wickerham DL, Gelber RD, Flynn PJ, Weir LM, Intra M, Jones WO, Perez EA, Hartman LC. Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study. J Clin Oncol 2009;27:3620-6.
  • Dumesic DA, Patankar M, Barnett D, Lesnick T, Hutcherson B, Abbott DH. Early prenatal androgenization results in diminished ovarian reserve in adult female rhesus monkeys. Hum Reprod 2009;24:3188-95.
  • Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, Lobo R, Norman RJ, Talbott E, Dumesic DA. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a position statement by the Androgen Excess & Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010;95:2038-2049.
  • Abbott DH, Bruns CR, Barnett DK, Dunaif A, Dumesic DA, Goodfriend TL, Tarantal AF. Experimentally-induced gestational androgen excess disrupts glucoregulation and stimulates growth in fetal and neonatal female rhesus monkeys. Am J Physiol Endocrinol Metab. 2010;299(5):E741-51.
  • Chazenbalk GD, Bertolotto C, Heneidi S, Jumabay M, Trivax B, Aronowitz J, Yoshimura K, Simmons CF, Dumesic DA, Azziz R. Novel pathway of adipogenesis through cross-talk between adipose tissue macrophages, adipose stem/progenitor cells and adipocytes: evidence of cell plasticity. Plos One 2011;6:e17834.
  • Goodarzi M, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219-231.
  • Azziz R, Dumesic DA, Goodarzi M. Polycystic Ovary Syndrome: an ancient disorder? J Clin Endocrinol Metab. Fertil Steril 2011;95:1544-1548.
  • Dumesic DA, Pasch LA. Hirsuitism: bother or burden? Developing a patient-centered management approach. In press.
  • Fauser BCJM, Tarlatzis B, rebar R, Legro R, Balen A, Carmina E, Chang J, Yildiz B, Laven J, Boivin J, Petraglia F, Wijeyeratne, Norman R, Dunaif A, Franks S, Wild R, Dumesic D, Barnhart. Consensus on women’s health aspects of polycystic ovary syndrome. The Amsterdam ESHRE/ASRM-sponsored 3rd PCOS consensus workshop group. In press

Additional pubs in PubMed.gov

Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
Dr. Daniel Dumesic,  click here to update your profile.